Trial Profile
Central Macular Thickness, Macular Electroretinogram, and Visual Acuity in Patients With Diabetic Macular Edema After Intravitreal Aflibercept Injection. A One Month Pre-Post Intervention Follow Up Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 11 Jul 2018 Status changed from recruiting to completed.
- 06 Mar 2018 New trial record